Answer
Caution is advised with Soolantra (ivermectin) cream and potent CYP3A4 inhibitors because ivermectin is primarily metabolised by CYP3A4, so plasma exposure may be significantly increased; no interaction studies have been performed.
Sources for this answer
- Soolantra 10mg/g CreamGalderma (U.K.) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 10Document updated
Sources checked